Holger Jon Møller

Publications (link to AU profile)

The role of macrophages in inflammation and cancer focus on two main topics:

- Biomarker discovery development, validation and use of macrophage biomarkers in disease.

- Targeted therapy. Specific targeting of drugs to macrophages for antiinflammatory or immunomodulating effects.

Keywords: assay validation, CD163, CD206, SIRPα, Multiplex, ELISA, Flowcytometry, Nanosight, LCMS, Automation, ddPCR, myeloma, cancer, inflammation, polarisation, immunotherapy, checkpoints, microenvironment, Vitamin D.

 

Current PhD projects
 

Kristian Wiborg Antonsen

Targeted inhibition of phagocytosis checkpoints in tumor-associated macrophages

Started 08.2020

Financed by Danish Cancer Society

Co-supervisors: Søren K. Moestrup, Anders Etzerodt, Boe Sandahl Sørensen

Anne Juhl Nielsen

Vitamin D and Alveolar Macrophages in Idiopathic Pulmonary Fibrosis

Started 02.2021

Financed by Aarhus University and Frimodt-Heineke Fonden

Co-supervisors: Elisabeth Bendstrup, Rie Harboe Nygaard, Søren K. Moestrup


Henriette Nymark Friis

Macrophage "don't eat me" checkpoints as biomarkers to monitor immunotherapy in bladder cancer

Started 09.2023

Financed by the Independent Research Fund Denmark, Danish Cancer Research Fund and Thora og Viggo Groves Mindelegat

Co-supervisors: Torben Steiniche, Molly Ingersoll, Lars Dyskjøt Andersen